Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer-Aided Drug Discovery Approaches over the Past Five Years
Ayanda M. Magwenyane, Samuel Chima Ugbaja, Daniel G. Amoako, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 22

Showing 22 citing articles:

An update on the status of HSP90 inhibitors in cancer clinical trials
Shraddha Rastogi, Abhinav Joshi, Nahoko Sato, et al.
Cell Stress and Chaperones (2024) Vol. 29, Iss. 4, pp. 519-539
Open Access | Times Cited: 16
Heat‐Shock Proteins
Adam T. Hagymasi, Joseph P. Dempsey, Pramod K. Srivastava
Current Protocols (2022) Vol. 2, Iss. 11
Closed Access | Times Cited: 38
Functionalized Nanomaterials for Inhibiting ATP-Dependent Heat Shock Proteins in Cancer Photothermal/Photodynamic Therapy and Combination Therapy
Thejas P. Premji, Banendu Sunder Dash, Suprava Das, et al.
Nanomaterials (2024) Vol. 14, Iss. 1, pp. 112-112
Open Access | Times Cited: 10
Emerging Promise of Computational Techniques in Anti-Cancer Research: At a Glance
Md. Mominur Rahman, Md. Rezaul Islam, Firoza Rahman, et al.
Bioengineering (2022) Vol. 9, Iss. 8, pp. 335-335
Open Access | Times Cited: 27
Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies
Nihal Abdelmoniem, Marwa H. Abdallah, Rua M. Mukhtar, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1771-1771
Open Access | Times Cited: 19
Recent advances toward the development of Hsp90 C-terminal inhibitors
Eva Amatya, Brian S. J. Blagg
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 80, pp. 129111-129111
Open Access | Times Cited: 25
Lymph node dissection does not affect the survival of patients with tumor node metastasis stages I and II colorectal cancer
Fan He, Shu-Pei Qu, Ye Yuan, et al.
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 8, pp. 2503-2510
Open Access | Times Cited: 3
Importance of targeting various cell signaling pathways in solid cancers
Chandrayee Ghosh, Jiangnan Hu
International review of cell and molecular biology (2024), pp. 101-155
Closed Access | Times Cited: 1
Molecular pathway of anticancer effect of next-generation HSP90 inhibitors XL-888 and Debio0932 in neuroblastoma cell line
Özlem Kaplan, Nazan Gökşen Tosun
Medical Oncology (2024) Vol. 41, Iss. 8
Open Access | Times Cited: 1
C-terminal domain dimerization in yeast Hsp90 is moderately modulated by the other domains
Maria Oranges, Angeliki Giannoulis, Anna Vanyushkina, et al.
Biophysical Journal (2023)
Open Access | Times Cited: 3
Remission of Nonalcoholic Fatty Liver Disease After Radical Surgery in Patients with Colorectal Cancer: A Single-Center Retrospective Study
Ziwei Li, Xin‐Peng Shu, Fei Liu, et al.
Metabolic Syndrome and Related Disorders (2024) Vol. 22, Iss. 3, pp. 207-213
Closed Access
HSP90 is part of a protein complex with the L polymerase of Rift Valley fever phlebovirus and prevents its degradation by the proteasome during the viral genome replication/transcription stage
Farhang Alem, Ashwini Brahms, Kaori Tarasaki, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Synthesis and Experimental Structure of a Multifunctional Catechol‐Azomethinebenzoic Acid, DFT/DMol3Calculations, and Molecular Docking with Hsp90
Hana Bashir Shawish, Hela Ferjani, Ismail M. Taban, et al.
ChemistrySelect (2024) Vol. 9, Iss. 19
Closed Access
CUL-6/cullin ubiquitin ligase-mediated degradation of HSP-90 by intestinal lysosomes promotes thermotolerance
Mario Bardan Sarmiento, Spencer S. Gang, Patricija van Oosten‐Hawle, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114279-114279
Open Access
Previously Unrecognized and Potentially Consequential Challenges Facing Hsp90 Inhibitors in Cancer Clinical Trials
Cheng Chang, Xin Tang, David T. Woodley, et al.
Cell Stress and Chaperones (2024) Vol. 29, Iss. 5, pp. 642-653
Open Access
Human Target Proteins for Benzo(a)pyrene and Acetaminophen (and Its Metabolites): Insights from Inverse Molecular Docking and Molecular Dynamics Simulations
Y. P., Nérlis Pájaro-Castro, Nadia Coronado‐Posada, et al.
Scientia Pharmaceutica (2024) Vol. 92, Iss. 4, pp. 55-55
Open Access
PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond
Sameh Saber, Rasha Abdelhady, Mai A. Elhemely, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer
Desh Deepak Singh, Shafiul Haque, Youngsun Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Identification of promising cancer target proteins of major sesquiterpene lactones from Vernonia spp
Muhammad Faisal, Potchanapond Graidist, Varomyalin Tipmanee
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-12
Closed Access
Therapeutic Potential of Heat Shock Protein 90 Inhibitors, Geldanamycin, and Analog Compounds in Precision Cancer Therapy
Attaa Mohammed Alzebari, Amjad Mahmood Qadir, Mahmood Sherzad Rafaat, et al.
BioMed Target Journal (2023) Vol. 1, Iss. 2, pp. 2-21
Open Access | Times Cited: 1
Tool and Techniques on Computer-Aided Drug Design for Targeted Cancer Therapy
V. G. Niveditha, V. Sindhu, Moni Philip Jacob Kizhakedathil, et al.
Biological and medical physics series (2023), pp. 781-829
Closed Access
CUL-6/cullin ubiquitin ligase-mediated degradation of HSP-90 by intestinal lysosomes promotes thermotolerance
Mario Bardan Sarmiento, Spencer S. Gang, Patricija van Oosten‐Hawle, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top